Bicarbonate

Bicarbonate

SCHEMBL711064

O=C([O-])[O-].O=C([O-])[O-].O=C([O-])[O-].[Ca+2].[Ca+2].[Ca+2]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA4 P22748 5/20 0.50
CA1 P00915 3/20 0.50
FAHD1 Q6P587 1/20 0.50
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.39
LDHA P00338 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
CASP1 P29466 1/20 0.36
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL8435181 1.00 CA4 (0.50) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL3266233 1.00 CA4 (0.50) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL7926706 1.00 CA4 (0.50) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL532723 1.00 CA4 (0.50) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL9145494 1.00 CA4 (0.50) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL9146197 1.00 CA4 (0.50) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL8059663 1.00 CA4 (0.50) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL3261 1.00
Bicarbonate SCHEMBL1331961 1.00
Bicarbonate SCHEMBL1537736 1.00 CA4 (0.50) CA4CA1FAHD1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-222197696-U Sieving device for producing tricalcium carbonate 江苏晓春新材料有限公司 2024-12-20 CN claimed
CN-221776393-U Storage device for storing tri-calcium carbonate 江苏晓春新材料有限公司 2024-09-27 CN claimed
CN-118489324-A Rapid raw soil curing method and device for effectively improving soybean yield 浙江省农业科学院 2024-08-16 CN claimed
CN-113912343-B Building plastering mortar suitable for robot and preparation method thereof 浙江建工新材料有限公司 2022-12-23 CN claimed
CN-115159485-A Preparation method of pure tricalcium phosphate 连云港树人科创食品添加剂有限公司 2022-10-11 CN claimed
CN-114477770-A Phosphate microcrystalline glass and preparation method thereof 方益琴 2022-05-13 CN claimed
CN-113912343-A Building plastering mortar suitable for robot and preparation method thereof 浙江建工新材料有限公司 2022-01-11 CN claimed
CN-113796521-A Health product for old people for supplementing calcium and regulating blood fat and blood pressure and preparation process thereof 烟台圣莱恩康复医院有限公司 2021-12-17 CN claimed
CN-111233435-A Glazed ceramic product and preparation method thereof 德化县宏顺陶瓷有限公司 2020-06-05 CN claimed
CN-110981427-A Ceramic artwork prepared from waste ceramic and preparation method thereof 福建省德化佳浩陶瓷有限公司 2020-04-10 CN claimed
CN-110885251-A Green fruit glaze ceramic artwork and preparation method thereof 福建省德化佳浩陶瓷有限公司 2020-03-17 CN claimed
US-20030046777-A1 EMULSION OF WATER SOLUBLE DYES IN A LIPOPHILIC CARRIER KEE ACTION SPORTS CANADA, INC. (F/K/A AJ ACQUISITION CANADA, INC.) 2003-03-13 US claimed
WO-2003018905-A1 EMULSION OF WATER SOLUBLE DYES IN A LIPOPHILIC CARRIER R.P. SCHERER TECHNOLOGIES, INC. (US) 2003-03-06 WO claimed
US-6414066-B1 BLEND OF THERMOSETTING BINDER AND RESIDUE OF DEPOLYMERIZED NYLON 6 WASTE CARPET ALLIEDSIGNAL INC. 2002-07-02 US claimed
US-20260014293-A1 HEMOSTATIC AGENT IN PASTE FORM, USE THEREOF, AND METHOD FOR PRODUCING A LOCAL ACTIVE AGENT RELEASE SYSTEM HERAEUS MEDICAL GMBH (DE) 2026-01-15 US disclosed
EP-4678196-A1 PASTY HAEMOSTYPTIC, ITS USE AND A METHOD FOR THE PREPARATION OF A LOCAL DRUG DELIVERY SYSTEM Heraeus Medical GmbH (DE) 2026-01-14 EP disclosed
CN-119220219-A Double-component polyurethane elastic structural adhesive suitable for bonding plastic substrates of automobile spoilers and preparation method thereof 杭州之江有机硅化工有限公司 2024-12-31 CN disclosed
EP-0104630-A2 Animal growth promotant and method of use for animal growth FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-04-04 EP disclosed
US-4352821-A FRUCTOSE, WATER INSOLUBLE SALT AS CARRIER SHAKLEE CORPORATION (US) 1982-10-05 US disclosed
US-4209518-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260014293-A1 HEMOSTATIC AGENT IN PASTE FORM, USE THEREOF, AND METHOD FOR PRODUCING A LOCAL ACTIVE AGENT RELEASE SYSTEM F9, PLAT, F12 CA4 2987/4885CA1 3418/4885FAHD1 4782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.